Session Information

JOS Session

[JOS Oral: O5] Age-Related Macular Degeneration 2
Go back
print
Day
Apr 04 (Fri)
Time
10:30 - 11:30
Room
Room 19 - Imperial Hotel 2F Botan
Topic
[JOS Session] Retina, Vitreous
Chair/Coordinator
Chair)Mitsuko Yuzawa

O2-020 / 

[JOS Session] Retina, Vitreous

Treat and adjust regimen using aflibercept for refractory exdative AMD

Akiko Yamamoto

Treat and adjust regimen using aflibercept for refractory exdative AMD

O2-021 / 

[JOS Session] Retina, Vitreous

OCT findings in Aflibercept therapy for AMD resistant to ranibizumab

Koji Tanaka

OCT findings in Aflibercept therapy for AMD resistant to ranibizumab

O2-022 / 

[JOS Session] Retina, Vitreous

Aqueous VEGF and aflibercept level 2 months after aflibercept injection for AMD

Tomoko Sawada

Aqueous VEGF and aflibercept level 2 months after aflibercept injection for AMD

O2-023 / 

[JOS Session] Retina, Vitreous

Intravitreal aflibercept for AMD affects aqueous levels of angiostatic factors

Shunichiro Ueda

Intravitreal aflibercept for AMD affects aqueous levels of angiostatic factors

O2-024 / 

[JOS Session] Retina, Vitreous

Changes of intravitreal VEGF recepter in AMD during the treatment of aflibercept

Ryosuke Motohashi

Changes of intravitreal VEGF recepter in AMD during the treatment of aflibercept

Go back